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Abstract 
Background: The ability to successfully transfer knowledge across international boundaries to improve health across 
the European Region is dependent on an in‑depth understanding of the many factors involved in policy creation. 
Across countries we can observe various approaches to evidence usage in the policy‑making process. This study, 
which was a part of the Models of Child Health Appraised (MOCHA) project assessing patterns of children’s primary 
care in Europe, focused on how and what kind of evidence is used in child health policy‑making processes in Euro‑
pean countries and how it is applied to inform policy and practice.
Method: In this study, a qualitative approach was used. The data were analysed in accordance with the thematic 
analysis protocol. The MOCHA project methodology relies on experienced country agents (CA) recruited for the 
project and paid to deliver child health data in each of 30 European countries. CAs are national experts in the child 
health field who defined the country‑specific structured information and data. A questionnaire designed as a semi‑
structured survey instrument asked CAs to indicate the sources of evidence used in the policy‑making process and 
what needed to be in place to support evidence uptake in policy and practice.
Results: In our data we observed two approaches to evidence usage in child health policy formulation. The scientific 
approach in our understanding refers to the so‑called bottom‑up initiatives of academia which identify and respond 
to the population’s needs. Institutional approaches can be informed by scientific resources as well; however, the 
driving forces here are governmental institutions, whose decisions and choices are based not only on the popula‑
tion needs but also on political, economic and organizational factors. The evidence used in Europe can also be of an 
external or internal nature. Various factors can affect the use of evidence in child health policy‑making. Facilitators are 
correlated with strong scientific culture development, whereas barriers are defined by a poor tradition of implement‑
ing changes based on reliable evidence.
Conclusions: Focusing on the facilitators and actively working to reduce the barriers can perceivably lead to faster 
and more robust policy‑making, including the development of a culture of scientific grounding in policy creation.
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Background
There are many different patterns of children’s primary 
care in Europe, which leads to many different policies 
and different health outcomes of children throughout 
the European Union (EU) and European Economic Area 
(EEA) countries [1]. One aim in improving children’s 
public health is to understand why some countries have 
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successful policies in children’s health and good pat-
terns of child health through effective services, and oth-
ers struggle to achieve the same results. The successful 
transfer of knowledge across international boundaries 
to improve health across the European Region requires 
an in-depth understanding of the many aspects involved 
in policy creation and identifying relevant transferabil-
ity criteria [2]. An important factor in achieving this is 
understanding national influences on policy-making.
The use of evidence in the process of policy formula-
tion is one of the prerequisites for successful policy-
making. Evidence, understood as “findings from research 
and other knowledge that may serve as a useful basis for 
decision-making in public health and health care” [3, 4], 
helps in implementing solutions which are responsive to 
the population needs and are acceptable to the popula-
tion. However, we should remember that “Evidence alone 
does not make decisions” [5]. Firstly, it informs expert 
opinions, but it is not in itself expert opinion. Secondly, 
to be convincing, it must be based on research that uses 
standardized and systematic methodologies. Finally, it 
has to be of high quality, and therefore trustworthy [5].
It is important, therefore, to investigate the impact of 
context in the process of policy-making and also in the 
use of evidence to support the policy. Bowen and Zwi 
highlight an important aspect of the context within 
which evidence is used: “A key challenge to public health 
is to better contextualize evidence for more effective pol-
icy-making and practice” [6].
Across countries, there are various approaches to evi-
dence usage in the policy-making process. For exam-
ple, in Australia [7], a “strong institutional foundation 
for nurturing evidence-based policy (EBP) capacities” 
underpins policy development [8]. The United States 
has a long tradition of evidence-based policy-making as 
it “has been the major global location for policy analysis 
and evaluation professionals, both within government 
and in other policy-relevant sectors” [8]. In the United 
Kingdom attempts to “develop a coherent approach to 
policy development, championing EBP as a major aspect 
of the increased policy capability and the fresh thinking 
required by a reformist government” were undertaken 
in the early 2000s [8]. Hasanpoor et al. stressed that evi-
dence-based management “has been slowly adopted by 
healthcare managers in the USA, the United Kingdom 
and Canada” but a “remarkable gap exists between this 
ideal scenario and the status quo” [9].
Even though awareness of evidence-based solutions is 
increasing, there is still a significant need for the devel-
opment of standardized tools and identification of appro-
priate measures. Key global and European institutions 
are undertaking actions to support evidence-based pol-
icy-making. Developed by the European Commission, 
the “Knowledge for policy” portal provides support “to 
make informed policy decisions regarding the design of 
research and innovation policies or strategies” [10], with 
the goal of “[bridging] the science–policy gap by bring-
ing together evidence for policy from scientists across 
Europe, to policymakers across Europe” [11]. WHO has 
published a manual with guidance which helps to under-
stand what evidence-based policy is and provides techni-
cal support in the process of preparing, developing and 
conducting it [12].
In this study, we focused on the kind of evidence that is 
used in decision-making processes and how it is imple-
mented to inform policy and practice in child health 
policy-making in Europe [13]. This research is part of the 
Models of Child Health Appraised (MOCHA) project 
which aimed to assess the varied patterns of children’s 
primary care in Europe [14, 15]. “A key objective for 
MOCHA was firstly to describe the primary care systems 
in detail and their components and to appraise them 
from a number of different viewpoints, professional, pub-
lic (including parents, children and wider community), 
political and economic lenses” [16]. One of the goals of 
the project was to identify optimal patient-centred and 
prevention-oriented primary child healthcare models. 
The conditions for implementation of the alternative 
models, transferability and preferences of the public were 
tested at the macro, meso and micro levels.
This transferability analysis was supported by an assess-
ment of the culture of evidence-based policy-making. 
Our aim was to establish the extent of use of evidence, 
and the types of evidence that influence and underpin 
policy-making for children’s health and healthcare. We 
explored how policy decisions are made in the different 
countries, and the most common patterns of evidence 
used at the national health policy level in each MOCHA 
project country. To this end, we asked two research ques-
tions of national correspondents of countries within the 
EU and EEA Europe:
• How is evidence used in child health policy formula-
tion?
• What are the facilitators of and barriers to evidence 
usage in child health policy formulation?
Methods
Ethics
The MOCHA project was funded as an integrated 
research programme by the European Commission’s 
Directorate-General (DG) for Research  and Innovation. 
The research protocol, as enshrined in Grant Agree-
ment 634201, recognized the interlinking work between 
partners to holistically address the core research topic, 
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and was explicit in the use of country agents (CA) as 
field-level contributors, drawing on local sources but 
not involving personal data. The nature of a dynamic 
integrated study is such that each interdependent com-
ponent, one of which is reported in this paper, cannot 
be individually reviewed in an informed way at the insti-
tutional level. The Ethical Committee of the European 
Commission’s DG for Research and Innovation Horizon 
2020 programme was seen as the supranational ethical 
review committee, assessing the project in whole and as 
the sum of the parts. The strand of work reported here 
was explicitly included on page 10 of Grant Agreement 
634201, and the CA methodology on pages 128–129 of 
that document, which was scrutinized and approved by 
the Ethical Committee of the European Commission’s 
Research and Innovation Directorate as a prior requisite 
to the project being funded.
Study design
We used a qualitative approach in this study. The data 
were analysed in accordance with the thematic analy-
sis protocol proposed by the experienced qualitative 
researchers Braun and Clarke [17]. We conducted our 
research in a constructionist manner, which means that 
we sought to “theorise the socio-cultural contexts, and 
structural conditions” [17] of the evidence-based usage in 
child health policy-making in European countries.
Questions and questionnaire
The MOCHA project methodology relies on the experi-
ence of CAs in each of 30 EU and EEA countries. CAs 
were national experts in the child health field who defined 
country-specific structured information and data. The 
CAs were recruited, based on their knowledge and pro-
fessional experience, by the project coordinators (project 
principal investigator, project deputy principal inves-
tigator, research coordinator) and were paid to deliver 
child health data for each of the 30 European countries 
studied. Their contributions ensured that the findings of 
this paper were based on detailed and local indigenous 
knowledge. In line with the overall methodology devel-
oped by the MOCHA project, CAs were encouraged and 
trusted to gain a range of opinions within the country 
prior to distilling it into the formal answer to the ques-
tion. The answers from CAs were not personal opinions, 
and regular meetings with CAs confirmed that they were 
totally opposed to expressing personal opinions and 
always identified local robust sources according to each 
topic before providing the final answers to MOCHA 
researchers.
To analyse evidence-based approaches to child health 
policy in Europe, a questionnaire designed as a semi-
structured survey instrument was created (Additional 
file  1). The questions were formulated by topic lead 
researchers (the authors), approved by the project coor-
dination team of scientists, and validated by the project’s 
external advisory board (EAB), which ensured scientific 
and professional validity. The EAB comprised members 
nominated by European medical, paediatric and policy 
bodies, WHO Regional Office for Europe, United Nations 
Children’s Fund (UNICEF) Innocenti research centre, 
and civil society groups, and is published elsewhere [18].
The questionnaire was sent by the MOCHA research 
coordinator via email to each CA. CAs had 1 month to 
provide the answers. The electronic responses were gath-
ered by the MOCHA research coordinator and sent to 
the researchers responsible for the analysis.
Specifically, CAs were asked to indicate the sources of 
evidence used in the policy-making process and what 
needed to be in place to support evidence uptake in pol-
icy and practice by identifying up to three new child-ori-
ented policies developed within the past 3  years (either 
currently in operation or soon to be implemented) that 
affect child primary healthcare service provision. Exam-
ples of such policies which were put forward included 
vaccination policy, services for children with special 
needs, approaches to dealing with abused children, men-
tal health promotion in primary care and changes to out-
of-hours service availability. Other types of policy might 
concern general issues involving the provision of and 
access to care, human resources, or the organization of 
the system of financing. For each of their three selected 
examples, CAs were asked to (a) identify the policy, (b) 
characterize evidence used in formulating the policy and 
(c) point out what needed to be in place to support evi-
dence uptake in policy and practice in their countries 
(Additional file 1). The questions were asked in an open 
format.
We were aware of the consolidated criteria for report-
ing qualitative research (COREQ) approach [19], but it 
could not be applied directly to our study because the 
researchers did not engage directly in the field, but rather 
through the CAs, in order to obtain topical material in 
each national language. However, our methods map to all 
the key COREQ principles which are appropriate to this 
multinational study.
Survey
The data collection was carried out between July 2017 
and January 2018. The 30 CAs received the question-
naire by email from the research coordinator. CA repre-
sentatives of 23 countries—all of the EU member states 
at that time except Belgium, France, Germany, Latvia, 
Luxembourg, the Netherlands and Sweden, plus the 
EEA countries Iceland and Norway—responded to the 
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questionnaire. Lack of responses to the questionnaire by 
seven CAs was the result of work overload at that time, 
and overriding personal issues.
In total, 34 policy topics were identified which were 
related to child primary healthcare in European countries 
and described in terms of evidence used.
Data analysis
Braun and Clarke [17] define thematic analysis as a tool 
which enables the researcher to identify, analyse and 
report patterns (themes) within data. They offer a six-
phase guide, which we followed:
1. Familiarizing with the data in order to mark some 
ideas for coding. At that stage, we pre-reviewed the 
data and incorporated it into the computer software 
for qualitative analysis (NVivo 11).
2. Generating initial codes by creating a list of ideas 
about what is in the data that results in the creation 
of meaningful groups of data. We identified our data 
as latent (interpretative). For coding the data we used 
computer software. This helped us to tag and name 
selections of text within each data item. The data 
were coded phrase by phrase.
3. Identification of themes which, as recommended by 
Braun and Clarke [17], concentrate on “sorting the 
different codes into potential themes, and collating 
all the relevant coded data extracts within the identi-
fied themes” [17]. In our research we identified the 
themes in an inductive, bottom-up way, which ena-
bled our approach to avoid being driven by the pre-
existing coding frame.
4. Reviewing and refining themes, which led us to cre-
ate a thematic map.
5. Defining and naming themes.
6. Producing the report in the form of the presented 
paper.
Data availability
As previously explained in other works [20] under 
Horizon 2020 funding rules, the European Commis-
sion requires all data to be accessible to the greatest 
degree possible, while also recognizing the potential 
conflict between openness and confidentiality. To that 
the MOCHA team have added the importance of com-
prehension, as source data cannot be interpreted with-
out a clear understanding of the method of acquisition. 
The MOCHA data contain no patient information, but 
may contain other personal or institutional data such 
as source of a commentary. The MOCHA project has 
therefore resolved that source data will be curated on the 
MOCHA website, and will be accessible via the principal 
or other partners through a curator function, so that data 
relevant to any enquiry can be supplied, and redaction 
effected, but also contextualization given. The curator in 
this context is an informed data manager who will dis-
cuss the objective and meaning of the question so as to 
supply the required data in a contextually informed man-
ner; the role is analogous to a research librarian facilitat-
ing bibliographic searches.
Results
The results presented below are based on the CAs’ 
responses obtained. From the characteristics of the evi-
dence usage in child health policy formulation, we identi-
fied several structural approaches.
Types of evidence used in child health policy formulation
In our data we observed two approaches to evidence 
usage in child health policy formulation (Fig. 1). On the 
one hand, the responses of CAs show that the evidence 
used was based on experts’ reports/research studies and 
developed by professionals, and on the other hand, the 
baseline for formulating new policy was other policy 
documents or reports produced by administrative units. 
The scientific approach in our understanding refers to so-
called bottom-up initiatives of academia which identify 
and respond to the needs of the population. Institutional 
approaches can be informed by scientific resources as 
well; however, the driving forces here are governmental 
institutions, whose decisions and choices are based not 
only on the population needs but also on political, eco-
nomic and organizational factors.
Additionally, we observed that the data used in the 
child health policy formulation can be of an external or 
internal nature. External evidence refers to international 
resources and exchange of good practices between Euro-
pean countries, and internal evidence indicates domestic 
data produced nationally.
To understand our data in wider context we refer to 
the final MOCHA report where we explain how to bring 
MOCHA lessons to provided services [15, 21].
Scientifically produced evidence
Scientific data is a vital tool in the process of child health 
policy-making, and often it is the baseline for the devel-
opment of national and international recommendations 
and guidelines. Examples emerged from Austria, Greece 
and Spain, with subjects covering child health policy and 
primary healthcare reform.
The Greek reform of primary healthcare and imple-
mentation of urgent amendments under the mandate 
of the Ministry of Health and other provisions used a 
report by a working committee of academic professors 
and medical doctors as a stimulus. The document “Basic 
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Principles, Positions and Proposals for the Development 
of Primary Health Care in Greece”, was created in 2015 
in order to “identify problems of the primary health care 
system in Greece and provide suggestions on how to rec-
tify them based on evidence” (Greek CA).
Several CAs reported the use of research in the process 
of developing child health policy in their countries. For 
example, in Austria, when the new law on health reform 
implementation was enacted, the strong voice of paedia-
tricians was noticeable in the discussion on the new law, 
as they criticized the inadequate consideration of pri-
mary healthcare for children (Austrian CA). Systematic 
reviews, questionnaire surveys and overviews of reviews 
were carried out when the new mother and child health 
passport (MKP) was developed (Austrian CA).
The development of the “National Strategic Plan for 
Childhood and Adolescence 2013–2016 (II PENIA)” in 
Spain, a “strategic plan that seeks out the ‘need to for-
mulate a comprehensive strategy for children based on 
the principles and provisions of the Commission on the 
Rights of the Child’ is part of a global and international 
strategy for children and adolescents” (Spanish CA). 
The main principles of II PENIA are the best interest, 
non-discrimination, development of child potential and 
the right to quality education and participation (Span-
ish CA). To gain a better understanding of the situation 
of children, general statistical analyses were conducted 
to “continue the development of statistical compilations 
or publications about the ‘situation of children in Spain’ 
or ‘Children in figures‘ on a regular basis in order to 
develop series” (Spanish CA) and to “offer new statisti-
cal information on issues that affect children between 0 
and 18 years, disaggregated by sex, age, disability status 
and habitat” (Spanish CA). Additionally, the Spanish CA 
reported that a statistical bulletin of measures for child 
protection and a statistical bulletin of measures imposed 
on young offenders were in use.
Institutionally produced evidence
CAs reported several key sources of evidence from gov-
ernmental institutions and organizations. Examples from 
Denmark, Poland and Ireland show that the institutional 
initiatives to create evidence- and experience-based poli-
cies can be relevant here.
In Denmark, the amendment of the law on the use of 
coercion in psychiatry was the result of a political field 
of interest and discussion among the political spokes-
persons. The Danish CA stressed that “the government’s 
psychiatric committee completed a report that high-
lighted some points of impacts and recommendations in 
the field of psychiatry, and the possible need for changes 
in the Danish Mental Health Act” (Danish CA). The 
amendment “was based on a report, prepared by the gov-
ernment’s psychiatric committee. It was, therefore, more 
Fig. 1 Evidence used in child health policy‑making process
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experience-based rather than evidence-based. There was 
little focus on whether there was good evidence for the 
amendment of the law” (Danish CA).
In Poland, a new plan of coordinated care within pri-
mary care was preceded by several studies. In recent 
years, four main analyses have been undertaken in the 
field of primary healthcare in Poland, summarized in a 
report prepared by a team of experts appointed by the 
Minister of Health to develop strategies for systemic 
solutions in the area of primary care. The reports were 
titled “Analysis of Primary Health Care in Poland and 
proposal of systemic changes” 2016; the National Health 
Fund research report, “Primary Health Care—the poten-
tial and its usage” 2016; the audit report of the Supreme 
Audit Office, “Functioning of Primary and Outpatient 
Specialist Care Financed from public funds” 2014; and 
Ernst & Young Research Report “Optimization of the 
Polish System of Financing Primary Health Care” 2012 
(Polish CA).
In Ireland, debate emerged on Medical Card eligibility 
as part of the National Medical Card Unit Strategic Plan 
2016–2018. The Irish CA explained that “a Medical Card 
allows people to access Family Doctor or GP [general 
practitioner] services, community health services, dental 
services, prescription medicine costs, hospital care and 
a range of other benefits free of charge. The provision of 
a Medical Card is based on a means test. However, if a 
person’s income exceeds the threshold, but their individ-
ual circumstances place them at risk of ‘undue financial 
hardship’, including, for example, a child with a chronic 
illness, they may be granted a Discretionary Medi-
cal Card which provides the services as outlined above” 
(Irish CA). The evidence used in the national public 
debate comprised the findings of two reviews which were 
commissioned by the Health Service Executive to inform 
the development of the policy (Irish CA).
External evidence
Austria, Croatia, Denmark, Poland and the United King-
dom looked beyond their own boundaries to gain ideas 
on screening schedules, amblyopia, healthy living, oral 
health, anti-bullying environment and primary care coor-
dination. External evidence seemed to be called upon 
most when countries were already aware they needed 
new ideas.
The policy described by the Austrian CA had the goal 
of “evaluation, qualitative advancement, attractiveness 
and increased use as an instrument for the early screen-
ing and promotion of children”. To reach these objectives, 
the Ministry of Health launched an interdisciplinary pro-
cess aimed at the contemporary development of the MKP, 
which has operated since 1974 and is regularly amended. 
The planned implementation of the new mother–child 
screening, scheduled for 2018, was a further develop-
ment of the MKP. It developed the assessment of each 
item of the new screening concept based on international 
criteria and guidelines (WHO, German guidelines, etc.) 
(Austrian CA). Additionally, systematic reviews, budget 
impact analyses, questionnaire surveys, overviews of 
reviews and guidelines were carried out. The issues were 
also discussed during conferences such as the European 
Forum for Evidence-based Health Promotion and Pre-
vention in June 2017. In the second case described by the 
Austrian CA, international guidelines were used when 
the health reform legislation (Gesundheitsreformumset-
zungsgesetz 2017 - GRUG 2017) establishing primary 
healthcare centres was prepared. “Research regarding the 
evidence of PHC [primary healthcare] as well as interna-
tional comparisons of different models of PHC were the 
basis for the recommendations for the Austrian model” 
(Austrian CA).
The Croatian CA identified three areas of child health. 
Two of these, the national children’s Amblyopia plan and 
the national “Healthy Living” programme were directly 
linked with child health. The national strategic plan to 
improve oral health, despite not being exclusively focused 
on children’s oral health, devoted most of the docu-
ment and almost all of the activities to a focus on chil-
dren. In achieving this, an important role was played not 
only by professional pressure but also by international 
comparisons.
Experiences from other countries were used in Den-
mark in implementing the “Act on the Educational Envi-
ronment for Students”. This law was an anti-bullying 
policy that “gives children the right to complain to state 
authority, if the school/municipality does not take ade-
quate action to stop bullying” (Danish CA). The evidence 
on how bullying affects children’s health in the short and 
long term was used in formulating these recommenda-
tions. In particular, the experiences from Norway and 
Sweden were taken into account, as both of those coun-
tries have for many years had similar complaint boards 
against bullying.
In Poland, the implementation of a model of coor-
dinated care in primary healthcare was discussed. In 
accordance with the newly proposed model of coordi-
nated care, all care provided to a child should be per-
formed by a team of health professionals. Such team 
should consist of a physician, nurse, and midwife and in 
the future a health educator and dietician as well. In the 
process of preparing the reform, its authors referred to 
scientific studies and international experiences such as a 
report prepared by a team called to develop strategies for 
systemic solutions in the area of primary care, appointed 
by the Minister of Health—“analysis of Primary Health 
Care in Poland and proposal of systemic changes” 2016.
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The need for a policy on female genital mutilation 
(FGM) was raised in the United Kingdom. The United 
Kingdom CA stressed that the grassroots movement that 
raised the profile of FGM comprised London-based com-
munity groups such as Forward. A Member of Parliament 
(MP), Ann Clwyd (MP for Cynon Valley in Wales), took 
up the cause and lobbied parliament to make FGM ille-
gal in the United Kingdom, as well as to develop a policy 
to aid healthcare professionals. She added that “evidence 
collected by Forward and other community groups who 
lobbied for FGM to be made illegal in the United King-
dom was used”. Data from international charities were 
also used in campaigning by Ann Clwyd (United King-
dom CA).
Internal evidence
Other policies drew more upon national material. This 
seemed to apply primarily to situations when a current 
policy was being reviewed for effectiveness, as opposed 
to looking for new ideas, and occurred in the Czech 
Republic, Finland, Norway and Romania concerning 
patient rights for children, coercion in psychiatry, child 
and family service reform, free medical service eligibil-
ity, early intervention in families, legal framework for 
vaccination and sustaining healthy eating. These exam-
ples have a common theme of seeking to fine-tune and 
improve established policies; external evidence might be 
used as a secondary benchmark, as in one example.
In Norway, when the policy “Patients’ rights for chil-
dren”, aimed at empowering children and youngsters, was 
introduced, “the white paper documented cases remind-
ing of root cause analysis as in patient safety” (Norwegian 
CA). A unified political approach to safeguard children 
was presented in the major newspapers and television.
When a Finnish project of the Ministry of Social Affairs 
and Health and the Ministry of Education and Culture—
called "The programme to address reform in child and 
family services”—for the years 2016–2018 was created, 
an analysis of both the shortcomings and the strengths 
of the current situation was conducted. “Shortcomings 
in the management and integration of the services and 
in encountering clients are well documented. Services 
in many health and social care settings are scattered to 
many sectors and are mainly organized based on admin-
istrative branches. At the same time, there are numer-
ous examples of successful developments of new service 
structures and services. The programme plan combines 
these results” (Finnish CA).
Denmark’s policy on early intervention for vulnerable 
families (Tidlig indsats for sårbare familier) is a political 
agreement. It was funded by a public funding pool, the 
Satspuljemidler, which specializes in supporting social, 
health and work-related dimensions, particularly the 
most vulnerable in society. “Prior to the implementation 
of the policy, a mapping was carried out to determine 
who the vulnerable and disadvantaged children and fami-
lies are, what initiatives the municipalities have for the 
families, and the detection and categorization methods 
used in the different municipalities” (Danish CA).
In Romania, the decline in vaccine coverage and an 
increase in measles outbreaks, as well as a lack of some 
of the vaccines in the national vaccination scheme, 
prompted the Ministry of Health to establish a legal 
framework for vaccination and the purchase of vaccines. 
The evidence used in the process of policy development 
was based on government documents and analyses. “Evi-
dence for drafting the new Law on Immunization was 
presented in the Exposure of Motives published on the 
10.04.2017 by the Ministry of Health” (Romanian CA). 
This report also relies on “examples from 11 of the 28 EU 
countries, where vaccination is compulsory and children 
cannot be admitted in public education institutions with-
out certificates of immunization” (Romanian CA).
In the Czech Republic a campaign called “Prepare 
your snack yourself” was initiated. It aimed to change 
the eating habits of Czech school children and involved 
children in preparing their own nutritionally balanced 
snacks. This was a plan to combat the childhood obesity 
trend. An association called “Healthy eating in schools” 
composed of parents, students, counsellors, nutritional 
therapists and other professionals on healthy lifestyle 
wanted to involve more than 150 schools in this initia-
tive. This led to the formulation of the “Snack Decree” 
and methodical recommendations of the Ministry of 
Education, Youth and Sports and the Ministry of Health, 
and nutrition recommendations from the Czech Minis-
try of Health for evaluation of food provided by school 
canteens/cafeterias/restaurants. The evidence used in 
the preparation of the documents was based on the opin-
ions of nutrition health experts of the Ministry of Health 
and National Institute of Public Health and in consulta-
tion with children’s nutritionists from the Czech Medical 
Association (Czech CA).
Evidence uptake in policy and practice: facilitators 
and barriers
CAs were asked to describe the elements which facilitate 
and impede the approach to evidence-based practice in 
their country. This led to the identification of facilitators 
and barriers in the evidence uptake in child health pol-
icy and practice in European countries. Several patterns 
were observed.
Based on the responses of the CAs, we created catego-
ries of codes and grouped them as main themes which 
describe elements that facilitate and impede the evi-
dence-based approach in Europe (Fig. 2).
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Amongst the facilitators, we identified the follow-
ing categories: education of actors/stakeholders/public, 
awareness, funds, supportive environment, quality, lob-
bying, assistance with moving from evidence to decision, 
and finally scientific culture development, which can 
include all the components mentioned above.
Barriers were grouped as follows: difficulties with 
applying and using research/systematic reviews, poor 
data and information “control” or “management”, lack 
of will, lack of popularization achieved by scientific 
research, lack of mechanisms to stimulate cross-sectoral 
cooperation, lack of proper coordination and intersecto-
ral collaboration, lack of time, lack of resources, lack of 
national monitoring, lack of culture of neutral and impar-
tial information, and poor tradition of implementing 
political changes based on reliable evidence, which can 
include all the components mentioned earlier.
Facilitators
Education is a key factor in evidence use in policy-mak-
ing. Decision-makers should be knowledgeable about 
the sources and possibilities for use of evidence, which 
can be beneficial for the policy and decision-making 
process. Support of evidence-based practice and policy 
through education about evidence-based solutions was 
stressed by the Norwegian CA. In Denmark, “the Dan-
ish Health Authority offers method courses in working 
with national clinical guidelines. Such courses contain an 
introduction to and explain how to assess the risk of bias 
and other sources of uncertainty in studies and across 
studies. The purpose of these courses is to disseminate 
information and knowledge about the method and the 
work with the national clinical guidelines” (Danish CA). 
Finland proposed the use of a handbook of early inter-
vention to implement evidence-based early support, care 
and parental skills tools in practice (Finnish CA).
Educative initiatives increase awareness about evi-
dence use. In Portugal, “there is a general recommenda-
tion about increasing the recognition of research, related 
to health and to the definition of health needs, program 
implementation and program evaluation” (Portuguese 
CA). The Portuguese CA also stressed the importance 
of lifelong training as a measure which provides sustain-
ability, and she highlighted the role of “professional life 
long training; support from evaluation agencies that may 
monitor implementations and feedback the public poli-
cies” (Portuguese CA).
It is not only the awareness of existing evidence that 
matters; awareness of the context—for example, the 
social factors or patients’ preferences—is also significant 
Fig. 2 Facilitators and barriers in evidence uptake
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in facilitating evidence usage. The Bulgarian CA stressed 
that “the obvious truth is that the outcome of treatment 
of many chronic diseases depends on the effect of the 
medical measures, depends on the social environment in 
which these measures are undertaken. If these social fac-
tors are not taken into account, there is a high risk that 
the medical measures are not implemented” (Bulgar-
ian CA). From the perspective of the Austrian CA, “ele-
ments which will facilitate evidence-based practice are, 
for instance, that objective facts which should be taken 
as decision support, (…) evidence should be seen as com-
plementary by considering experience and patients’ pref-
erences” (Austrian CA).
Both categories, education and awareness, can assist 
with moving from evidence to decision and recom-
mendations—in other words, from evidence to policy-
making. Evidence should be highly relevant to existing 
problems. The Norwegian CA recommended conducting 
systematic literature searches with the sorting of results 
(as a brief report) as an important starting point for a 
specific review.
The Irish CA stressed that, amongst the elements 
which can facilitate evidence usage, there might be a mix-
ture of political orientation and access to funds with sup-
portive staff aimed at providing evidence-based medicine 
and healthcare services within their given budget (Irish 
CA). This led us to identify two new categories of facilita-
tors: funds and supportive environment.
Sufficient time and funding as a key factor in evidence 
use was stressed by the British CA, who noted that “clini-
cal practitioners need to be encouraged to participate in 
research and so require time as well as funding to do this” 
(United Kingdom CA). This goes hand in hand with the 
financial possibilities of the formulation of a unit contrib-
uting to evidence-based decisions. Such an institution 
was created in Norway in 2011. Several Norwegian direc-
torates established a “Unit for Social Welfare Research” 
whose mandate was to “contribute to evidence-based 
decisions about policy and practice in Norwegian welfare 
services, especially by conducting systematic reviews” 
(Norwegian CA).
The concept of a supportive environment refers to 
the support from evaluation agencies that may monitor 
implementation and feedback regarding public policies 
(Portuguese CA) and “the strong engagement of pub-
lic services stakeholders (at national, regional and local 
level), and also third sector organisations (…) together 
with child rights advocacy groups and research and edu-
cational institutions” (Spanish CA). Performing consul-
tancy work such as assistance with applications, research 
bids, assessing single studies, and research and develop-
ment was significant from the perspective of the Nor-
wegian CA. Amongst factors influencing the support of 
evidence uptake in policy and practice is the literacy of 
the involved stakeholders, as stressed by the Czech CA. 
He pointed out that “the involvement of the various Soci-
eties of the Czech Medical Association of J. E. Purkyně: 
Czech Society of Adolescent Medicine, Czech Endocri-
nology Society, Czech Society for Obesitology, Czech 
Pediatric Society, Society of PLDD (GPs for Children and 
Adolescents)” is beneficial (Czech CA).
The Finnish CA stressed how consultation with experts 
can affect evidence-based policy-making. He noted that 
“the major decisions are made by politicians, but the civil 
servants usually ask expert opinions before decision-
making. In Finland, the national and regional authorities 
with knowledge on child and adolescent health and ser-
vices as well as evidence-based practices are frequently 
consulted. In this case, a larger scale project was initiated 
and it was given to THL, the National Institute for Health 
and Welfare, which is the leading institute in health and 
welfare services in Finland” (Finnish CA).
In addition to the importance of stakeholder involve-
ment, the quality of the network of experts was men-
tioned by the Slovak CA. He proposed to “create expert 
working groups with these experts as well as significant 
authorities from public service involved” (Slovak CA) 
to support evidence use in his country. The Polish CA 
added that access to highly qualified scientific staff and 
high-quality education in medical professions are signifi-
cant facilitators as well. In Romania, it is important that 
“correct information should always come from profes-
sionals who can provide scientific evidence” (Romanian 
CA).
This would consequently affect the quality of evidence 
and encourage its use. The Norwegian CA added that 
“further research development work in summarizing 
qualitative studies” (Norwegian CA) is a crucial facili-
tator as well. Another  facilitator of evidence use worth 
stressing is the development of “evidence for informed 
decision-making on the effect of interventions in social 
welfare services by conducting systematic reviews and 
other secondary research—by producing plain-language 
summaries of existing systematic reviews” (Norwegian 
CA).
Lobbying and professional pressure were mentioned 
by Croatian and Polish CAs as elements which can sig-
nificantly affect the design, uptake and implementation of 
evidence-based solutions.
Quality improvement is an important element of sci-
entific culture development. An Italian expert added 
that “schools should improve the scientific culture of 
pupils. Citizens should take greater account of the scien-
tific preparation of people who they are willing to elect. 
The ways of selecting political representatives should be 
changed and improved” (Italian CA).
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Openness to the adoption of evidence-based recom-
mendations is another component of scientific culture 
development. In Greece, “significant improvements have 
been made in the last few years, particularly in the area of 
medical prescriptions. For example, regarding the man-
agement of chronic diseases, evidence-based national 
guidance and management protocols have been adopted 
and are mandatory within the e-prescription system” 
(Greek CA).
For building the scientific culture, collaborative part-
nership between researchers and policy-makers and 
appropriate communication of new (usually) synthesized 
research relevant to the directorates (Norwegian CA) is 
needed. Facilitating active collaboration and communica-
tion among welfare directorates in Norway seems to be 
crucial for supporting evidence usage.
Barriers
One of the barriers which we observed based on analy-
sis of the data provided by CAs was a very poor tradi-
tion of implementing political changes based on reliable 
evidence, which can be interpreted as a lack of tradition 
of previous reforms with specific analyses of the present 
state of the health system—as reported by the Polish CA. 
Additionally “short experience in the field of science, 
business and politics” (Polish CA) was stressed.
The Norwegian CA considered as a challenge diffi-
culties with applying and using systematic reviews to 
inform policy. In Croatia, data and information “control” 
or “management” nationally needs to be improved, with 
the goal of focusing on “evidence-based policy-making” 
(Croatian CA). The CA from Cyprus also stressed that 
there is a lack of will to use evidence in the policy-making 
process, and it can significantly affect the use of evidence.
The resistance of the medical environment before 
implementing changes was also highlighted as a barrier 
by the Polish CA. Additionally, lack of popularization 
of achieved scientific research and lack of mechanisms 
to stimulate cross-sectoral cooperation were also men-
tioned as difficulties in applying evidence-based policy-
making in practice. This is closely correlated with lack 
of proper coordination and intersectoral collaboration 
highlighted by the Greek CA. In Greece, this problem is 
linked with “differences in the legislation of public health 
care regarding administrative work, unbalanced funding 
and expense cuts, unclear job descriptions and relation-
ships and cases of conflicting interests” (Greek CA).
The consequence of a lack of interest in evidence-based 
practice in child healthcare and healthcare policy can 
be lack of time or lack of resources, with the result that 
“trajectories do not run smoothly, and it happens that 
some actions are initiated or finished without a proper 
evaluation” (Portuguese CA). Lack of funds disrupts 
the adequate monitoring of actions and impedes the 
training of professionals (Portuguese CA). The Dan-
ish CA stressed that evidence-based initiatives require a 
resource-intensive approach. He noted that “an element 
that impedes the approach to evidence-based practice 
is that evidence-based practices are resource-intensive 
and require the employees to have strong competencies” 
(Danish CA). Another factor pointed out by the Dan-
ish CA was a lack of national monitoring of whether the 
guidelines were implemented and whether they were 
followed.
Lack of a culture of neutral information was observed 
by the Italian CA, who noted that “the habit of discussing 
on the basis of the opinion of authoritative experts is still 
deeply rooted. The culture of ‘neutral’ (as much as pos-
sible) information is lacking” (Italian CA).
Twofold media impact: facilitator and barrier effect
Use of evidence is strongly embedded in context. It was 
proved by the responses of CAs, which show that media 
can both facilitate and impede the development of the 
new health policies.
The Austrian CA stressed that several discussions took 
place in conferences such as the European Forum for 
Evidence-based Health Promotion and Prevention, when 
the new mother and child screening was implemented. 
However, she also emphasized that “it is also not always 
possible to meet all criteria of the evidence-based medi-
cine to one hundred percent. In some subjects, this is 
also difficult—for example, in paediatrics” (Austrian CA). 
In Croatia, it was the starting point for the vast majority 
of communications and discussion with the public when 
the national children’s amblyopia plan was introduced. 
Many countries reported that the information about the 
evidence used in the policy-making process was widely 
present in the media. This played a significant role in 
the broadcasting and distribution of evidence-based 
approaches in European countries.
Media as facilitator in the discussions was mentioned 
by the Greek CA, who said that “results and suggestions 
by the report were used mainly through news media (TV 
and printed press), in facilitated discussions between 
representatives of the political parties, health profession-
als and administrative staff of the health system” (Greek 
CA).
Media, including social media, also played a power-
ful role in Romania in influencing public opinion, when 
the new law on vaccination was drafted. However, the 
Romanian CA stressed that the media input did not nec-
essarily, or did not always, produce accurate or positive 
messages. A lack of neutrality was expressed. According 
to the Romanian CA, at the beginning of the vaccine cri-
sis, both state and private television invited at least one 
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anti-vaccination physician or active anti-vaccination 
campaigner on social media to give their views. Most of 
the time, these people participated alone in shows, with-
out the opportunity for debate or discussion of the plu-
rality of opinions. These shows had a large audience and 
were broadcast at times when they would reach the maxi-
mum audience. The most challenged vaccines were mea-
sles and polio, which were presented as having dangerous 
health consequences; others such as the BCG (bacillus 
Calmette-Guérin) vaccination were considered to have 
no positive effects, serving only the interests of pharma-
ceutical companies, who were portrayed as only inter-
ested in profit. At a later stage, when measles epidemics 
occurred, shifts in risk perception were noticeable in the 
media. The national media became an important actor 
advocating in favour of vaccination: “Journalists from 
TV and print media turned their campaign around and 
reported illness and death, and pressured governments 
to take concrete measures to limit the epidemics. These 
pressures forced the Health Ministry to clarify through 
press releases and new legislative regulations to avoid 
the vaccine crisis, whose priority cause is the lack of dose 
requirements for populations entering the national vac-
cination scheme” (Romanian CA).
It was also reported that the media were often focused 
on a single subjective case rather than objective debate. 
Lack of neutrality was identified by the Italian CA, who 
mentioned that “media often prefers to present a sin-
gle pathetic case (e.g. a baby died due to meningitis, or 
another has become autistic after a vaccination), instead 
of putting on a fair and objective debate (which would 
take a long time)” (Italian CA). Conversely “in the very 
intense public debate on media, expert opinions have 
been reported: ‘pro vs con’s’ style. Probably, there was 
a lack of presentation of evidence from literature, espe-
cially for healthcare professionals” (Italian CA). The Pol-
ish CA added that “the provisions of the Act of Primary 
Health Care differ significantly from those presented 
by the media. The main changes have not been fully 
presented, and the media has focused only on certain 
elements. The media was presenting as especially contro-
versial the fact that paediatricians were not included in 
the primary care team in the provisions of the Act (which 
was later changed). The critical voices of experts at the 
professional media portals dominated the discussion. 
Emotional media reports of tabloid media have also been 
reported, which caused alarm that children’s health is at 
risk” (Polish CA).
On the other hand, the Croatian national “Healthy 
Living” programme was also “highly visible in mass and 
social media in various forms including commercials 
and organising and visiting events and shows where the 
information, background and evidence together with 
education have been provided and awareness continu-
ously raised” (Croatian CA). Similarly in Romania, where 
the high death rate among measles cases “has turned a 
large part of the media in favour of the vaccination (…) 
as it has consistently presented the victims of the mea-
sles epidemic and has put pressure on the health minis-
try to explain and find a solution” (Romanian CA), media 
played an educative role in increasing awareness in the 
population. However, the Portuguese CA stressed that 
“media may highlight issues, but public policies are not 
dependent on media news but rather from identified 
needs”.
Discussion
Recognizing the importance of evidence-based solutions 
in policy-making is crucial for effective implementation 
of innovation within child health policy. In the process 
of evidence-informed policy-making, understanding 
who is producing evidence is important. WHO stresses 
that “expert opinion is more than just evidence” [5] 
because it contains facts, their interpretation and conclu-
sions [5]. Research evidence is considered more reliable 
than expert opinion because it “uses systematic meth-
ods to collect and analyse observations” [5]. Therefore, 
we sought to identify the level of research evidence that 
underpins national policy in EU and EEA countries.
Our study identified a few generic factors that may 
influence the efficiency and success of child health pol-
icy. We were particularly interested in the facilitators 
and barriers in the use of evidence in child health policy-
making in Europe.
We observed two key trends in potential evidence-
based knowledge transition in policy-making. On the one 
hand, the importance of academia and its achievements 
was stressed, and on the other hand the role of institu-
tional reporting was highlighted. We defined those types 
of approaches as scientific and institutional. The scien-
tific approach comprises so-called bottom-up initiatives 
from the professional scientific environment, whereas 
the institutional approach involves top-down evidence 
production, which is initiated by administrative institu-
tions. We found that the institutional approach seems 
to benefit from the scientific resources and presents its 
recommendations based on scientific achievements; thus 
the two groups are not mutually exclusive. This was also 
discussed by Cairney and Oliver [22], who reported that 
“successful engagement in ‘evidence-based policy-mak-
ing’ requires pragmatism, combining scientific evidence 
with governance principles, and persuasion to translate 
complex evidence into simple stories” [22].
The evidence used in Europe can also be described as 
of an external or internal nature. Such classification is 
consistent with the WHO approach, which considers 
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evidence through both global and local prisms [3]. Inter-
national comparisons play a significant role as a con-
textual determinant of child health policy-making [20]. 
They facilitate the exchange of good practices and pro-
vide information that is not always available nationally. 
Domestic evidence, on the other hand, is strongly con-
textualized. By definition, it devotes attention to nation-
ally sensitive issues which need to be resolved. Nationally 
produced data are a source of country-specific evidence, 
which should be crucial in national policy-making pro-
cesses. Successful policy-making seems to involve a com-
bination of international evidence that is applicable to 
nationally identified issues. This was seen as one of the 
key points of the Organisation for Economic Co-opera-
tion and Development (OECD) conference “Governing 
better through evidence-informed policy-making” in 
2017 [23]. The discussion on better leverage and connect-
edness of the existing international networks that exist to 
improve their effectiveness and diffuse their result raised 
the question, “how can international networks for evi-
dence create results that are relevant at the local level?” 
[23]. Our results address this question by indicating the 
means of evidence production at both levels as well as the 
direction of the relationship between them (Fig. 1).
Hasanpoor et al. highlighted that “the practical frame-
work of evidence-based management should be based on 
the best resources from identifying barriers and facilita-
tors” [9]. In our study we described both of these.
We found that various factors can affect evidence use 
in child health policy-making. Head, in 2010, pointed out 
three elements that underpin modern conceptions of evi-
dence-based policy: (i) high-quality information based on 
relevant topic areas, (ii) professionals with skills in data 
analysis and policy evaluation, and (iii) political incen-
tives for using evidence-based solutions in governmental 
decision-making processes [8]. Our analysis of facilita-
tors and barriers shows that policies are more likely to 
be transferable if they meet these three criteria for suc-
cess. In our study we highlighted the significance of the 
quality of the policy processes and quality of information, 
need for the development of a tradition of implement-
ing political changes based on reliable evidence and the 
demand for a supportive environment for evidence-based 
policy-making.
This was also found by Bach-Mortensen et  al. [24], 
who noted that the most frequently reported facilitat-
ing factors in their study were related to whether the 
evidence-based intervention aligned with the mission 
of the organization, the flexibility to implement the evi-
dence-based intervention, its perceived effectiveness 
and its organizational support and prioritization, and 
finally, supportive leadership. Our data show that lob-
bying groups have particular importance in the process 
of creating supportive environments, because they bring 
implementation of financial support to generate high-
quality evidence.
We found that barriers to evidence-based policy-mak-
ing include a poor tradition of implementing changes 
based on reliable evidence, which is also reflected in the 
paper by Bach-Mortensen et al. [24] as a set of determi-
nants which give rise to dysfunctional organizational cul-
ture. Where there are difficulties with the application and 
use of research evidence in policy, it tends to be because 
of poor data and information control or management. In 
the literature it is reflected in barriers related to policy-
maker research skills [25] or data management issues 
[24]. The reasons identified in our study include a lack of 
will amongst decision-makers to use such data, but also a 
lack of funds to support evidence-based solutions in pol-
icy-making. These elements are consistent with the work 
of Ellen et al. [26], who described limited resources and 
negative attitudes as key barriers to implementing sup-
port for evidence-informed decision-making in health 
systems. In our understanding, in order to overcome 
these barriers, activation of mechanisms to stimulate 
cross-sectoral cooperation and proper coordination of 
intersectoral collaboration are required.
Generic elements that were identified which affect evi-
dence-based solutions in policy-making constitute the 
phenomenon of a “culture of evidence-based policy-mak-
ing” (Fig. 3), which can be interpreted as a style of policy-
making where evidence is fundamental. Other authors 
have highlighted similar concepts in which knowledge 
translation culture [26] is understood as a “paradigm to 
address many of the challenges in translating research 
to knowledge users and start closing the ‘know–do’ gap” 
[26, 27].
In our understanding, the culture of evidence-based 
policy-making is broader, as it highlights not only chal-
lenges for the successful translation of evidence, but also 
explains the levels of evidence usage and shows the cor-
relation between them. It is important to appreciate that 
the culture of evidence-based policy-making exists in 
parallel with the policy-making cycle. It is based on the 
appreciation of the value of scientific research which sup-
ports and draws from institutional data. These data can 
be expressed at two levels: national, which reflects the 
internal approaches to evidence-based policy-making, 
and international, which expresses external views. The 
culture of evidence-based policy-making is strengthened 
by facilitators and weakened by barriers.
Limitations
The study on evidence usage in child health policy-
making in European countries is challenging, as evi-
dence usage is strongly contextualized. Some elements 
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such as perceptions and attitudes are often internalized 
and introspective, making their influences difficult to 
determine.
In our research we tried to identify the types of evi-
dence used and the factors which facilitate or impede 
evidenced-based policy-making. Although the MOCHA 
project had 30 national experts, we received responses 
from only 23 countries, as seven CAs did not provide 
responses to our questions. However, the nature of our 
research was not quantitative but qualitative; hence 
omission of some countries does not invalidate the data 
received. Our goal was to qualitatively investigate the key 
generic factors influencing evidence-based policy-mak-
ing and its impact on child health policy.
Practical implications
In this study we analysed factors which facilitate and 
impede evidence-based solutions within the context of 
child health policy in any country. We proposed guidance 
for stimulating effective reform processes with the goal of 
making the current factor analysis available to those who 
might wish to use it in their own reform process (Fig. 3).
Evidence-based child health policy-making needs an 
appropriate culture of evidence-based policy-making. 
Evidence usage is fundamental here; hence the crea-
tion of new policies and/or reforming current policies 
requires appropriate approaches based on available, 
high-quality evidence (Fig.  1). This might be scientific 
evidence produced by academic experts who are iden-
tifying existing problems that need to be solved and 
proposing appropriate steps to be undertaken. On the 
other hand, the evidence may come from institutions 
responsible for the reform or the introduction of new 
policy, or from analysis of problems with existing ser-
vices. Representatives of national governments or other 
expert units might initiate research, studies or analyses 
in the areas where potential change is needed. Evidence 
might be sought nationally or internationally.
Evidence usage in policy-making may be facilitated or 
impeded. The characteristics of both types of elements 
were presented previously (Fig.  2). An environment 
conducive to the use of evidence in child health policy-
making strengthens the culture of evidence-based pol-
icy-making, whereas lack of such an environment most 
Fig. 3 Culture of evidence‑based policy‑making
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probably will result in impeding a culture of evidence-
based policy-making.
With this in mind, we would like to propose the fol-
lowing guidance for decision-makers which we hope 
will facilitate and promote the culture of evidence-
based policy-making in their countries.
• Scientific evidence identifies and guides actions 
which need to be undertaken in the appropriate 
area.
• Institutional evidence relates to problems which have 
already emerged and need response from national or 
local institutions.
• Policy-making based on evidence usage truly 
responds to the population needs, identified scientifi-
cally and/or institutionally.
• Understanding that the facilitators of and barriers to 
evidence-based policy-making which we identified in 
our paper affect policy effectiveness.
Conclusions
A culture of evidence-based policy-making is understood 
as a style of policy-making where evidence is fundamen-
tal. We identified a number of barriers and facilitators 
in the use of evidence to support policy development or 
policy change. Focusing on the facilitators and actively 
working to reduce the barriers can potentially lead to 
faster and more robust policy-making, including the 
development of a culture of scientific grounding in policy 
creation.
• Two types of evidence usage exist: scientific and 
institutional. The first one we understand as initia-
tives of the professional scientific environment; the 
second refers to evidence production initiated by 
administrative institutions.
• The evidence used in Europe can be of an external or 
internal nature.
• Various factors can affect the use of evidence in child 
health policy-making. Facilitators are correlated with 
strong scientific culture development, whereas barri-
ers are defined by a poor tradition of implementing 
changes based on reliable evidence.
• Media are an important influence on the culture 
of evidence-based policy-making by facilitating or 
impeding evidence usage.
• The phenomenon of a culture of evidence-based 
policy-making is a style of policy-making where evi-
dence is fundamental.
• A culture of evidence-based policy-making highlights 
challenges for the successful translation of evidence 
into policy, explains the levels of evidence usage and 
shows the correlation between them.
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